FARALLON CAPITAL MANAGEMENT LLC Insider Trading $NVET Nexvet Biopharma plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FARALLON CAPITAL MANAGEMENT LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FARALLON CAPITAL MANAGEMENT LLC. FARALLON CAPITAL MANAGEMENT LLC is 10% Owner in CITY INVESTING CO LIQUIDATING TRUST ($CNVLZ) and 10% Owner in INSURANCE AUTO AUCTIONS, INC ($IAAI) and 10% Owner in MIG, INC. ($MTRM) and 10% Owner in CATALYTICA ENERGY SYSTEMS INC ($CESI) and 10% Owner in CAPITALSOURCE INC ($CSE) and 10% Owner in Nexvet Biopharma plc ($NVET).
FARALLON CAPITAL MANAGEMENT LLC in Nexvet Biopharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FARALLON CAPITAL MANAGEMENT LLC: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 02 2017
$NVET Market Capitalization: $40.45M
$NVET Previous Close: $3.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FARALLON CAPITAL MANAGEMENT LLC in Nexvet Biopharma plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CSE, CESI, CNVLZ, IAAI, MTRM, NVET
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 2,648,696 | 17,799,237 | 0 | 2.6 M to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 2,067,651 | 13,894,615 | 0 | 2.1 M to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 209,577 | 1,408,357 | 0 | 209.6 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 249,462 | 1,676,385 | 0 | 249.5 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 122,006 | 819,880 | 0 | 122 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 915,583 | 6,152,718 | 0 | 915.6 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 899,268 | 6,043,081 | 0 | 899.3 K to 0 (-100.00 %) |
| Aug 02 2017 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Sell | U | 6.72 | 833,845 | 5,603,438 | 0 | 833.8 K to 0 (-100.00 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 9,554 | 32,101 | 2,648,696 | 2.6 M to 2.6 M (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 65,694 | 208,907 | 2,639,142 | 2.6 M to 2.6 M (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 69,752 | 221,811 | 2,573,448 | 2.5 M to 2.6 M (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 7,458 | 25,059 | 2,067,651 | 2.1 M to 2.1 M (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 51,283 | 163,080 | 2,060,193 | 2 M to 2.1 M (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 54,451 | 173,154 | 2,008,910 | 2 M to 2 M (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 756 | 2,540 | 209,577 | 208.8 K to 209.6 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 5,198 | 16,530 | 208,821 | 203.6 K to 208.8 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 5,519 | 17,550 | 203,623 | 198.1 K to 203.6 K (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 900 | 3,024 | 249,462 | 248.6 K to 249.5 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 6,187 | 19,675 | 248,562 | 242.4 K to 248.6 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 6,569 | 20,889 | 242,375 | 235.8 K to 242.4 K (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 440 | 1,478 | 122,006 | 121.6 K to 122 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 3,026 | 9,623 | 121,566 | 118.5 K to 121.6 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 3,213 | 10,217 | 118,540 | 115.3 K to 118.5 K (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 3,303 | 11,098 | 915,583 | 912.3 K to 915.6 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 22,710 | 72,218 | 912,280 | 889.6 K to 912.3 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 24,112 | 76,676 | 889,570 | 865.5 K to 889.6 K (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 3,244 | 10,900 | 899,268 | 896 K to 899.3 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 22,304 | 70,927 | 896,024 | 873.7 K to 896 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 23,681 | 75,306 | 873,720 | 850 K to 873.7 K (+2.79 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.36 | 3,007 | 10,104 | 833,845 | 830.8 K to 833.8 K (+0.36 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 20,680 | 65,762 | 830,838 | 810.2 K to 830.8 K (+2.55 %) |
| Feb 26 2016 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 3.18 | 21,959 | 69,830 | 810,158 | 788.2 K to 810.2 K (+2.79 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 3,600 | 23,328 | 2,503,696 | 2.5 M to 2.5 M (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 100 | 575 | 2,500,096 | 2.5 M to 2.5 M (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 2,810 | 18,209 | 1,954,459 | 2 M to 2 M (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 78 | 449 | 1,951,649 | 2 M to 2 M (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 285 | 1,847 | 198,104 | 197.8 K to 198.1 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 8 | 46 | 197,819 | 197.8 K to 197.8 K (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 339 | 2,197 | 235,806 | 235.5 K to 235.8 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 9 | 52 | 235,467 | 235.5 K to 235.5 K (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 166 | 1,076 | 115,327 | 115.2 K to 115.3 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 5 | 29 | 115,161 | 115.2 K to 115.2 K (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 1,245 | 8,068 | 865,458 | 864.2 K to 865.5 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 35 | 201 | 864,213 | 864.2 K to 864.2 K (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 1,222 | 7,919 | 850,039 | 848.8 K to 850 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 34 | 196 | 848,817 | 848.8 K to 848.8 K (0.00 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 6.48 | 1,133 | 7,342 | 788,199 | 787.1 K to 788.2 K (+0.14 %) |
| Sep 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | P | 5.75 | 31 | 178 | 787,066 | 787 K to 787.1 K (0.00 %) |
Page: 1